SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-036407
Filing Date
2018-02-08
Accepted
2018-02-08 17:00:56
Documents
8
Period of Report
2018-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d439817d8k.htm 8-K 20666
2 EX-1.1 d439817dex11.htm EX-1.1 146308
3 EX-5.1 d439817dex51.htm EX-5.1 10604
4 EX-99.1 d439817dex991.htm EX-99.1 10837
5 EX-99.2 d439817dex992.htm EX-99.2 11001
6 GRAPHIC g439817g0207222922073.jpg GRAPHIC 4272
7 GRAPHIC g439817g0207222933563.jpg GRAPHIC 4272
8 GRAPHIC g439817g26l26.gif GRAPHIC 3095
  Complete submission text file 0001193125-18-036407.txt   217077
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 18586448
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences